Duarte, California 91010


Purpose:

This trial will pilot a psychosocial intervention called Conquer Fear Support (CFS) in patients with stage III-IV lung or gynecologic cancer who are experiencing fear of cancer progression. The intervention is adapted from a novel program called "Conquer Fear" which was developed by researchers in Australia. CFS may help in reducing worries, fears, and uncertainty in patients with advanced lung or gynecological cancer.


Study summary:

PRIMARY OBJECTIVES: I. Assess the feasibility and acceptability of the CFS intervention in patients with advanced lung and gynecologic (GYN) cancer (stages III or IV) who have clinically significant levels of fear of cancer progression (FOP) or cancer-related distress. SECONDARY OBJECTIVES: I. Assess preliminary effects of the intervention on FOP, cancer-specific distress, anxiety, depression, overall symptom distress, metacognitions, and mindfulness. OUTLINE: Patients attend CFS psychosocial intervention consisting of 7 nurse-led sessions (session 1 in-person and sessions 2-7 via video conferencing) over 45 minutes each for 8 weeks. Patients also complete home practice assignments comprising attention training technique and mindfulness practice sessions after each session. After completion of study intervention, patients are followed up at week 12.


Criteria:

Inclusion Criteria: - Patients with gynecologic (GYN) and lung cancer will be recruited - Stage III or IV disease - At least 3 months from initial diagnosis - Receiving disease-focused treatment or active surveillance mode - A score of ≥ 34 on the Fear of Progression Questionnaire-Short Form (SF) or ≥ 24 on the Impact of Event Scale-Revised - All subjects must have the ability to understand and the willingness to sign a written informed consent Exclusion Criteria: - Current severe depression or psychosis; significant cognitive impairment - Patients enrolled in hospice care or who opt to receive no further disease-focused treatment - Patients who are currently receiving ongoing psychiatric treatment - Non-English speaking


NCT ID:

NCT03776253


Primary Contact:

Principal Investigator
Anne Reb, NP, PhD
City of Hope Medical Center


Backup Contact:

N/A


Location Contact:

Duarte, California 91010
United States

Anne Reb, NP, PhD
Phone: 626-256-4673
Email: areb@coh.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.